Skip to main content
. 2020 Sep 6;10(9):e037238. doi: 10.1136/bmjopen-2020-037238

Table 3.

Primary and secondary outcomes

Outcome Definition/annotation
Primary outcome
28 day survival rate after arrival at the ED Patients whose survival/death information on 28th day after arrival at the ED is unclear are defined as drop-outs and will be excluded from the primary outcome analysis
Secondary outcome
Time to death during the first 28 days after arrival at the ED
In-hospital survival rate
Cumulative transfusion amounts
 Red blood cell concentrate Cumulative amounts during the first 1, 7 and 28 days after arrival at the ED
 Fresh-frozen plasma Cumulative amounts during the first 1, 7 and 28 days after arrival at the ED
 Platelet concentrate Cumulative amounts during the first 1, 7 and 28 days after arrival at the ED
Event-free days during the first 28 days after arrival at the ED
 Ventilator-free days When the patient dies during the first 28 days after the arrival at ED, the free days are defined as zero
 Catecholamine-free days When the patient dies during the first 28 days after the arrival at ED, the free days are defined as zero
ICU-free days When the patient dies during the first 28 days after the arrival at ED, the free days are defined as zero
Organ failure during the first 7 days after arrival at the ED
 Renal failure Stage III defined by the Kidney Disease Improving Global Guidelines
 Hepatic failure Total bilirubin level ≥6 mg/dL as per the Sequential Organ Failure Assessment score
 Respiratory failure Moderate acute respiratory distress syndrome according to the Berlin definition
Complications during in-hospital stay or the first 28 days after arrival at the ED
 Deep venous thrombosis Presence or absence should be diagnosed using clinical imaging
 Pulmonary embolism Presence or absence should be diagnosed using clinical imaging
 Cerebral infarction Presence or absence should be diagnosed using clinical imaging
 Acute myocardial infarction Presence or absence should not be diagnosed using only an elevation of cardiac biomarkers
 Bowel ischaemia Presence or absence should not be diagnosed using laboratory data
 Transfusion-associated lung injury Presence, possibility or absence are defined using the Toronto definition
 Sepsis Presence or absence should be diagnosed using the Sepsis-3 definition
Glasgow outcome scale score at discharge from the hospital Good recovery, moderate disability, severe disability, persistent vegetative state or death

ED, emergency department; ICU, intensive care unit.